Flagellate dermatitis after bleomycin chemotherapy in a patient with malignant germ cell tumor

被引:2
|
作者
Schummer, C. [1 ]
Winkler, Y. [2 ]
Tittelbach, J. [1 ]
Grimm, M. -O. [2 ]
Elsner, P. [1 ]
机构
[1] Univ Klinikum Jena, Klin Hautkrankheiten, D-07743 Jena, Germany
[2] Univ Klinikum Jena, Urol Klin, D-07743 Jena, Germany
关键词
flagellate dermatitis; bleomycin; testicular cancer; SHIITAKE DERMATITIS; MUSHROOM; ERYTHEMA;
D O I
10.1055/s-0033-1359878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and clinical findings: A 49-year-old patient with malignant germ cell tumor within the first cycle PEB (platinum [P], etoposid [E] and bleomycin [B]) presented with an itchy linear papular erythema with discrete vesicles. The rash had appeared three days ago i.e. four days after the second application of bleomycin. Investigations: Visual diagnosis of a flagellate dermatitis. Treatment and clinical course: Primary treatment consisted of systemic antihistamines, local and systemic application of steroids. Bleomycin treatment was stopped and substituted by ifosfamide. Conclusion: Flagellate dermatitis occurs with an incidence up to 66% after bleomycin treatment. There is no association between bleomycin dose and incidence or severity of the lesions. Flagellate dermatitis is a self-limiting condition but hyperpigmentation may persist. Similar lesions may occur with bendamustine and docetaxel, the intake of insufficiently cooked shiitake mushrooms as well as in dermatomyositis and Still's syndrome.
引用
收藏
页码:84 / 86
页数:3
相关论文
共 50 条
  • [1] Flagellate dermatitis in a patient with testicular germ cell neoplasia on bleomycin
    Mavridou, Konstantina
    Karakasi, Aggeliki
    Lampri, Evangeli
    Gaitanis, George
    Bassukas, Ioannis D.
    DERMATOLOGY REPORTS, 2023, 15 (04)
  • [2] Flagellate dermatitis in bleomycin chemotherapy: a causality?
    Indrastuti, Niken
    Mariyani, Sri
    Meidiyanti, Prima
    BMJ CASE REPORTS, 2022, 15 (07)
  • [3] FLAGELLATE DERMATITIS AFTER BLEOMYCIN
    MIORI, L
    VIGNINI, M
    DERMATOLOGICA, 1990, 181 (03): : 238 - 239
  • [4] FLAGELLATE DERMATITIS AFTER BLEOMYCIN - A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY
    MIORI, L
    VIGNINI, M
    RABBIOSI, G
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1990, 12 (06) : 598 - 602
  • [5] Bleomycin cardiotoxicity during chemotherapy for an ovarian germ cell tumor
    Didagelos, M.
    Boutis, A.
    Diamantopoulos, N.
    Sotiriadou, M.
    Fotiou, C.
    HIPPOKRATIA, 2013, 17 (02) : 187 - 188
  • [6] Bleomycin-induced flagellate dermatitis in a patient with Hodgkin lymphoma
    Danesin, Nicola
    Cellini, Alessandro
    Piazza, Francesco
    Trentin, Livio
    Visentin, Andrea
    MEDICINA CLINICA, 2024, 162 (08): : 406 - 406
  • [7] The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
    Lee, G. W.
    Park, J. Y.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 94 - 95
  • [8] The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
    Lee, G.
    Park, J. Y.
    Kim, D. Y.
    Suh, D. S.
    Kim, J. H.
    Kim, Y. M.
    Kim, Y. T.
    Nam, J. H.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S96 - S96
  • [9] THE SAFETY AND EFFICACY OF BLEOMYCIN, ETOPOSIDE AND CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH MALIGNANT OVARIAN GERM CELL TUMOR
    Lee, G. W.
    Lee, S. W.
    Park, J. Y.
    Kim, D. Y.
    Suh, D. S.
    Kim, J. H.
    Kim, Y. M.
    Kim, Y. T.
    Nam, J. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1620 - 1620
  • [10] The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor
    Park, J. Y.
    Kim, D. Y.
    Suh, D. S.
    Kim, J. H.
    Kim, Y. M.
    Kim, Y. T.
    Nam, J. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 803 - 803